Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pentasa (Mesalamine)

D W Claussen

    Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
    |December 1, 1993
    PubMed
    Summary
    This summary is machine-generated.

    Pentasa, an oral 5-aminosalicylic acid capsule, is now available for treating ulcerative colitis. This new medication effectively induces remission and manages mild to moderate symptoms with a favorable side effect profile.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Aciphex (rabeprazole).

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2000
    Same author

    Celebrex (celecoxib).

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2000
    Same author

    Mirapex: pramipexole dihydrochloride tablets.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2000
    Same author

    Chemotherapy drugs: an overview for the digestive system.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·1999
    Same author

    Kenalog-10 (triamcinoclone acetonide).

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·1999
    Same author

    Remicade (infliximab).

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·1999
    Same journal

    The Public Trust in Nursing: Is It Waning?

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    Same journal

    Budd-Chiari Syndrome Due to Protein C Deficiency: A Case Report.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    Same journal

    Lead Time and Tailored Messaging Promote Early-Onset Colorectal Cancer Prevention and Screening.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    Same journal

    Minimum Registered Nurse Staffing for Patient Care in the Gastroenterology/Endoscopy Setting.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    Same journal

    Ergonomic Considerations in ERCP Practice.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    Same journal

    Factors Associated With Intention to Undergo Colonoscopy Reexamination Based on Pender's Health Promotion Model: A Cross-Sectional Study.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    See all related articles

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Ulcerative colitis is a chronic inflammatory bowel disease affecting over 2 million Americans.
    • It is a debilitating gastrointestinal condition requiring effective management strategies.

    Purpose of the Study:

    • To introduce Pentasa (mesalamine) as a new oral treatment option.
    • To highlight its efficacy in inducing remission and treating ulcerative colitis.

    Main Methods:

    • Oral administration of Pentasa (mesalamine) capsules.
    • Clinical application for managing ulcerative colitis symptoms.

    Main Results:

    • Pentasa is indicated for the induction of remission in ulcerative colitis.
    • It is effective for treating mildly to moderately active disease.
  • The medication is generally well-tolerated with few side effects.

    • Conclusions:

    • Pentasa offers a new therapeutic option for ulcerative colitis patients.
    • Its tolerability and efficacy make it a valuable treatment choice.